World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.

Slides:



Advertisements
Similar presentations
World Tuberculosis Day 2013 TB situation in 2011: Findings from the ECDC and WHO/EURO joint TB surveillance report ECDC TB Team European Centre for Disease.
Advertisements

M. Samarkos TUBERCULOSIS IN GREECE. INTRODUCTION.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Tuberculosis Day 2015 The TB situation in 2013: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Tuberculosis in the UK 2013 report
Surveillance report Annual Epidemiological Report on communicable diseases in Europe ECDC Surveillance Unit European Centre for Disease Prevention and.
The Global Plan to Stop TB, (1)
2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Three key messages on tuberculosis control World Tuberculosis Day 2010 ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Assessing the public health challenge posed by Hepatitis B and C in the EU European Centre for Disease Prevention and Control Information for members of.
Sexually Transmitted Infections in Europe, 2012 European Centre for Disease Prevention and Control.
2014 HIV/AIDS Surveillance in the European Union and European Economic Area (EU/EEA) European Centre for Disease Prevention and Control, Stockholm WHO.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
2010 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Tuberculosis in the EU: An ECDC perspective World TB day European Parliament 22 March 2007 Zsuzsanna Jakab ECDC Director.
Table 1. Numbers and rates of TB cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Peter Cegielski, MD, MPH Team Leader for Prevention, Care and Treatment Global Tuberculosis Branch Division of Global HIV and TB Reinforcing the Surveillance.
Table 1. Number and rate of reported confirmed syphilis cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,
Table 1. Confirmed cases of Typhoid and paratyphoid fever: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
Figure 1. Weekly proportion of sentinel specimens positive for influenza virus and number of detections by type and subtype, EU/EEA, 2014–2015 Suggested.
Table 1. Reported confirmed hepatitis A cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
World Tuberculosis Day 2014
World Tuberculosis Day 2013
World Tuberculosis Day 2014
Sexually Transmitted Infections in Europe, 2012
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Figure 1. Number of reported hantavirus infection cases, EU/EEA, 2014
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
World Tuberculosis Day 2015
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Table 1. Reported, confirmed campylobacteriosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes,
Table 1. Number and rate of reported confirmed syphilis cases per 100 000 population by country and year, EU/EEA, 2010–2014 Country
Table 1. Reported confirmed brucellosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
Tuberculosis situation in the EU/EEA, 2016
HIV/AIDS Surveillance in Europe 2011
European Centre for Disease Prevention and Control
Gonorrhoea cases of gonorrhoea were reported by 27 EU/EEA Member States for The overall notification rate was 18.8 cases per 100 000 population.
Brief overview of HIV among MSM in the EU/EEA
World Tuberculosis Day 2014
World Tuberculosis Day 2016
World Tuberculosis Day 2014
Table 1. Table 1. Reported confirmed salmonellosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
Table 1. Reported confirmed VTEC infection cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N.
Table 1. Reported confirmed cholera cases, EU/EEA, 2010–2014
Table 1. Reported confirmed botulism cases: number and rate per population, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:
Lymphogranuloma venereum (LGV)
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Table 1. Reported confirmed leptospirosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N.
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
Chlamydia In 2016, cases of chlamydia infection were reported in 26 EU/EEA Member States. The overall notification rate was 184 per 100 000 persons.
Table 1. Confirmed cases of trichinellosis: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N = no,
EXERCISE 11: Computing and Analyzing Program Indicators
Source: Country reports
Trends for ECDC measles and rubella monitoring,
Surveillance, Monitoring and Evaluation Working Group
Table 1. Reported confirmed listeriosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
Tuberculosis situation in the EU/EEA, 2017
Table 1. Table 1. Reported confirmed toxoplasmosis cases: number and rate per live births, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
Annual Epidemiological Report for 2017 Sexually Transmitted Diseases - chlamydia - gonorrhoea - lymphogranuloma venereum - (congenital) syphilis.
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis in Wales Annual Report 2017 Data to the end of 2016
Tuberculosis situation in the EU/EEA, 2017
Table 1. Reported confirmed yersiniosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
Presentation transcript:

World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014 ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March 2016

Monitoring Four epidemiological indicators Eight core indicators 2

Epidemiological indicators 3

Indicator 1: Trends in case notification rate 2010−2014* 4 * Estimated data for Italy for 2014 Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, Target: Mean declining trend over the previous five years Status 2014: 27 countries met the target

Indicator 2: Trends in multidrug-resistant TB case notification rate, Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, Target: Mean declining trend over the previous five years Status 2014: 17 countries met the target

Indicator 3: Trends in child-to-adult notification ratio 6 Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, Target: Mean declining 10-year trend in child-to-adult notification ratio Status 2014: Thirteen countries met the target

Indicator 4: Trends in mean age of TB cases 7 Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, Target: Increasing 10-year trend Status 2014: Twelve countries met the target

Epidemiological indicators Summary, EU/EEA, 2014: Trend in TB notification rate: Target: decreasing 5-year trend. EU/EEA status: Mean annual change, 2010 to 2014 was – 5.6% Trend in MDR TB notification rate: Target: decreasing 5-year trend. EU/EEA status: Mean annual change, 2010 to 2014 was – 1.8% Trend in ratio of notification rate in children to adults*: Target: decreasing 5-year trend, met by 13 countries. EU/EEA status: Mean annual change, 2010 to 2014 was 1.0% Trend in mean age of TB cases*: Target: increasing 10-year trend, met by 12 countries. EU/EEA status: Mean annual change, 2005 to 2014 was 0.2% 8 * Member States’ level indicator. Not applicable for EU level. Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, 2016.

Core indicators 9

Indicator 1 and 2: Availability of national TB control plan and implementation guidelines* 10 Information not available National TB control plan not available National TB control plan available with implementation guidelines * Data obtained from ECDC questionnaire survey National TB control plan available without implementation guidelines Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, Target: All countries have national TB control plans available and implementing guidelines Status 2014: 15 countries have a national TB control plan, 13 countries have a plan with guidelines for implementation

Indicator 3: Percentage of national TB reference laboratories achieving adequate performance in the external quality assessment (EQA) scheme 11 Status 2014*: Nine national reference laboratories from nine country participated in the EQA for all four diagnostic methods and all (100%) laboratories achieved a performance of ≥ 80% for all four methods. Target: 100% of national TB reference laboratories achieving ≥ 80% performance (smear, culture, first- and second-line drug susceptibility testing). Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, *Results for 2014 report obtained from European Reference Laboratory Network for Tuberculosis (ERLTB-Net). No country-specific data are available.

Indicator 4: Availability of a strategy for introducing and implementing new tools for TB control* 12 Information not available or country not reporting Strategy for new tools for TB control not available Strategy for new tools for TB control available * Data obtained from ECDC questionnaire survey Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, Target: All Member States (100%) have a strategy within the national TB programme supporting the introduction and implementation of new tools for TB control Status 2014: Nine (37.5%) countries have a strategy in place

Indicator 5: Percentage of new pulmonary TB cases confirmed by culture 13 Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, Target: 80% of new pulmonary TB cases are culture confirmed Status 2014: 72.7% of new pulmonary TB cases were culture confirmed, 12 countries met the target

Indicator 5: Percentage of new pulmonary TB cases tested by DST for first-line drugs 14 0 to 84.9% 100% 85 to 99.9% Not reporting Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, Target: 100% of TB cases tested for susceptibility to first- line drugs (isoniazid and rifampicin) among new pulmonary TB cases Status 2014: For 72.7% of culture-confirmed TB cases DST was reported, eight countries met the target

Indicator 6: Percentage of Member States reporting treatment success rate 15 Treatment outcome not reported Treatment outcome reported Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, Target: All Member States (100%) report treatment outcome monitoring to ECDC Status 2014: 27 EU/EEA Member States reported treatment outcome for TB cases notified in 2013

Indicator 7: Treatment success rate 16 Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, Target: Treatment success rate of at least 85% for new pulmonary culture-confirmed TB cases Status 2014: Treatment success rate for EU/EEA was 75.9% (range: 0–100.0%), target met by five countries

Indicator 7: Treatment success rate new pulmonary culture positive MDR TB cases* 17 * Luxembourg reported ‘zero’ cases; France, Greece, and Italy did not report treatment outcome results. Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, Target: Treatment success of 70% for new pulmonary culture- positive MDR TB cases Status 2014: Success rate in EU/EEA was 55.6% (range 0– 100.0%), target met by 6 countries

Indicator 8: Percentage of TB patients for whom HIV status is known to 74.9% 100% < 50% 75 to 99.9% Not included or not reporting * Finland and Poland reported HIV-positive cases, but not the number of tested cases for HIV, therefore excluded Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, Target: HIV status is known for 100% of notified TB cases Status 2014: 21 countries reported HIV test results for 36.6% of all reported cases, the 100% target was not met

Core indicators Summary, EU/EEA, 2014: National TB plan availability*: Target: TB plan available, met by 15 countries. EU/EEA status: not met Availability of guidelines for implementing the national TB control plan*: Target: TB guidelines available, met by 13 countries. EU/EEA status: not met Laboratory EQA performance: Target: 100% of reference lab’s achieving 80% of performance (culture, smear and DST), met by 9 laboratories (100% of reporting). EU/EEA status: met Availability of a New Tool strategy*: Target: New Tool strategy available, met by 9 countries. EU/EEA status: not met 19 * Member States’ level indicator. Not applicable for EU level. Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, 2016.

Core indicators Summary, EU/EEA, 2014: Culture-confirmation: Target: 80% of culture confirmation in new pulmonary TB cases. EU/EEA status: 72.7% Drug susceptibility testing, Target: 100% of culture-confirmed cases tested for first-line drugs. EU/EEA status: 85.2% Treatment success reporting: Target: 100% of EU/EEA Member States are reporting treatment success. EU/EEA status: 90.0% Treatment success rate: Target a: 85% of new pulmonary TB cases treated successfully in 12 months. EU/EEA status: 75.9% Target b: 70% of new pulmonary MDR TB cases treated successfully in 24 months. EU/EEA status: 55.6% Known HIV status: Target: Known HIV status for 100% of notified TB cases. EU/EEA status: 36.6% 20 Source: European Centre for Disease Prevention and Control. TB surveillance and monitoring in Europe, 2016.

Progressing towards TB elimination: how’s the EU doing? INDICATORS MET  / NOT MET  at EU LEVEL Epidemiological Indicators reflect both trends in disease burden and in the level of transmission Trends in TB case notification rate  Trends in MDR-TB case notification rate  Trends in child-to-adult ratio of notification rates  Trends in mean age of TB cases  Core Indicators are related to the 8 strategic areas of the Framework Action Plan Availability of a national TB control plan  Availability of guidelines for implementing the national TB control plan  Percentage of National TB reference laboratories achieving adequate performance in the external quality assurance scheme  Availability of a strategy for introducing and implementing new tools for TB control  Percentage of new pulmonary TB cases confirmed by culture and percentage of new cases tested by DST for first-line drugs  Percentage of Member States reporting treatment success rate  Treatment success rate  Percentage of TB patients for whom HIV-status is known 